Echoviruses and coxsackie B viruses that use human decay-accelerating factor (DAF) as a receptor do not bind the rodent analogues of DAF
Related Experiment Video
Updated: Oct 18, 2026

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
Published on: July 15, 2019
O B Spiller1, I G Goodfellow, D J Evans
1Complement Biology Group, Dept. of Medical Biochemistry, University of Wales College of Medicine, Heath Park, Cardiff, CF4 4XX, United Kingdom. SpillerB@cardiff.ac.uk
Abstract:
Many serotypes of echovirus (EV) and Coxsackie B virus (CBV) bind human decay-accelerating factor (DAF) and use it as a receptor for infection. Analogues for DAF have been isolated from mice and rats and characterized; these analogues have amino acid identities to human DAF of approximately 60%. EV serotypes 3, 6', 7, 11-13, and 29 and CBV serotypes 1, 3, and 5 caused hemagglutination of human erythrocytes but not rat or mouse erythrocytes, suggesting failure to bind rodent DAF. To confirm this evidence, radiolabeled viruses were incubated with transfected Chinese hamster ovary (CHO) cells that were abundantly expressing each type of DAF. Only cells that expressed human DAF bound virus. Although binding of EV and CBV was specific for human DAF, complement inhibition by DAF expressed in CHO cells was similar for each analogue.
Insights
Echoviruses and Coxsackie B viruses infect humans by binding to decay-accelerating factor (DAF). These viruses do not bind to rodent DAF, indicating species-specific viral entry mechanisms.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Many echovirus (EV) and Coxsackie B virus (CBV) serotypes utilize human decay-accelerating factor (DAF) as a cellular receptor for infection.
- Rodent DAF analogues share approximately 60% amino acid identity with human DAF.
Purpose of the Study:
- To investigate the species specificity of DAF as a receptor for EV and CBV infection.
- To determine if rodent DAF analogues can serve as receptors for these viruses.
Main Methods:
- Hemagglutination assays using human, rat, and mouse erythrocytes.
- Binding assays with radiolabeled EVs and CBVs incubated with Chinese hamster ovary (CHO) cells expressing human or rodent DAF.
Main Results:
- EV and CBV serotypes tested caused hemagglutination of human erythrocytes but not rodent erythrocytes.
- Radiolabeled viruses specifically bound to CHO cells expressing human DAF, but not rodent DAF.
- While binding was human DAF-specific, complement inhibition by expressed DAF was similar across species.
Conclusions:
- EV and CBV binding and subsequent infection are specific to human DAF, not rodent analogues.
- This species-specific interaction highlights distinct viral tropism mechanisms.
- DAF's role in complement inhibition is conserved, despite species-specific viral binding differences.
More Related Videos
Related Concept Videos
Inhibitors Of Virion Release
Rabies
Retrovirus Life Cycles
Retroviruses
Inhibitors of Virion Maturation and Assembly
Viruses with RNA Genomes

